Researchers evaluated the burden of hepatitis C virus infection among adult patients with HIV infection in the United States during the era of direct-acting antiviral therapy.

Researchers at UW are pioneering long-acting injectable HIV therapies that have the potential to simplify and expand ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

Wesley Sundquist, a biochemist at University of Utah, and Tomas Cihlar, a virologist at Gilead, a biopharmaceutical company, ...

Many Americans were relieved when the Supreme Court left the Affordable Care Act in place following the law's third major ...

Kenyans seeking HIV treatment are no longer ushered to separate clinics for services.They now join the normal hospital queues and are served in the general clinics, a move known as integration.The ...

HIV infection are increasing in certain regions and communities. And it doesn’t help that stigma, misinformation, and shame ...

Some of them between 50 and 70% of their budgets for HIV diagnosis, treatment and prevention is coming from the United States," she said on "CBS Mornings Plus." "There's not really any other ...

NORTHAMPTON, MA / ACCESS Newswire / April 8, 2025 / In 2019, Somchai, a Thai native, was 21 years old and faced a double threat to his long-term health and wellbeing. He was living with hepatitis B (H ...

The use of mobile health care units that distribute ART and PrEP medications increased uptake among people who inject drugs, ...

Dual Trials Accelerate VELDONA® Toward Rare Disease Market EntryBridging Strategy Aims to Fast-Track U.S. Regulatory Approvals SAN DIEGO, CALIFORNIA / ACCESS Newswire / April 14, 2025 / Ainos, Inc. (N ...

On Tuesday, mass layoffs across the Department of Health and Human Services included the gutting of programs at the Centers ...